This list is an analysis based on recent market events. It's not an investment recommendation.
Waverley Pharma, Inc. is a pharmaceutical company, which engages in the commercialization and development of oncology drugs. Its products include Pemetrexed, WAV-102, and PARP-1 Inhibitors. The company was founded in 2014 and is headquartered in Winnipeg, Canada.
FAQs
What is Waverley Pharma stock price today?▼
The current price of WAVE.V is $0.02 USD — it has increased by +0% in the past 24 hours. Watch Waverley Pharma stock price performance more closely on the chart.
What is Waverley Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on TSX Venture Exchange exchange Waverley Pharma stocks are traded under the ticker WAVE.V.
Is Waverley Pharma stock price growing?▼
WAVE.V stock has risen by +100% compared to the previous week, the month change is a +100% rise, over the last year Waverley Pharma has showed a +0% increase.
What is Waverley Pharma market cap?▼
Today Waverley Pharma has the market capitalization of 1.08M
What is Waverley Pharma revenue for the last year?▼
Waverley Pharma revenue for the last year amounts to 1.35M USD.
What is Waverley Pharma net income for the last year?▼
WAVE.V net income for the last year is -499,000 USD.
In which sector is Waverley Pharma located?▼
Waverley Pharma operates in the Health & Wellness sector.
When did Waverley Pharma complete a stock split?▼
Waverley Pharma has not had any recent stock splits.
Where is Waverley Pharma headquartered?▼
Waverley Pharma is headquartered in Winnipeg, Canada.